Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches-Reference-Cited by-同舟云学术

Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches

Published:2019-06-04 Issue: Volume:6 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Bodet-Milin Caroline,Bailly Clément,Touchefeu Yann,Frampas Eric,Bourgeois Mickael,Rauscher Aurore,Lacoeuille Franck,Drui Delphine,Arlicot Nicolas,Goldenberg David M.,Faivre-Chauvet Alain,Barbet Jacques,Rousseau Caroline,Kraeber-Bodéré Françoise

Publisher

Frontiers Media SA

Subject

General Medicine

Reference34 articles.

1. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning;Goldenberg;N Engl J Med,1978

2. Antibodies and antimatter: the resurgence of immuno-PET;Wu;J Nucl Med Off Publ Soc Nucl Med,2009

3. Immuno-PET of cancer: a revival of antibody imaging;Boerman;J Nucl Med Off Publ Soc Nucl Med,2011

4. Immuno-PET for clinical theranostic approaches;Bailly;Int J Mol Sci,2016

5. ImmunoPET to help stratify patients for targeted therapies and to improve drug development;Kraeber-Bodere;Eur J Nucl Med Mol Imaging,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging;Pharmaceutics;2024-06-30

2. CEACAM5-Targeted Immuno-PET in Androgen Receptor–Negative Prostate Cancer;Journal of Nuclear Medicine;2024-05-23

3. Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer;Molecular Cancer Therapeutics;2024-04-18

4. The present and future of bispecific antibodies for cancer therapy;Nature Reviews Drug Discovery;2024-03-06

5. Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities;Reviews in Endocrine and Metabolic Disorders;2023-09-16